Company Listing
Tizona Therapeutics

Tizona Therapeutics is a US immunotherapy company developing a pipeline of novel antibody therapeutics with potential in a broad range of cancers and autoimmune diseases. Tizona’s lead candidate is expected to start clinical trials in 2017 for cancer.  President and CEO Pablo Cagnoni, formerly President of Onyx Pharmaceuticals, a subsidiary of Amgen, leads the experienced management team.

BACK
Location
South San Francisco, California
CEO
Pablo Cagnoni
Abingworth Partner
Shelley Chu
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Tizona Therapeutics is a US immunotherapy company developing a pipeline of novel antibody therapeutics with potential in a broad range of cancers and autoimmune diseases. Tizona’s lead candidate is expected to start clinical trials in 2017 for cancer.  President and CEO Pablo Cagnoni, formerly President of Onyx Pharmaceuticals, a subsidiary of Amgen, leads the experienced management team.

Location
South San Francisco, California
CEO
Pablo Cagnoni
Abingworth Partner
Shelley Chu
Website Address
BACK
 
Copyright Abingworth 2017